DEF: Wrap Technologies Annual Meeting: Share Increase & Equity Plan Focus

Sentiment:

Proxy Statement


Wrap Technologies announces its 2026 Annual Meeting, proposing key proposals including a significant increase in authorized shares, an amendment to its equity compensation plan, and changes to its charter to streamline preferred stock amendment voting.

Capital raiseThe proposal to increase authorized shares from 200,000,000 to 300,000,000 is intended to provide flexibility for future capital raising transactions.The proposal to authorize the issuance of shares of common stock underlying Series C Preferred Stock, which could be in excess of 20% of outstanding shares, directly relates to potential future share issuances.The company has engaged in multiple private placements of common stock and warrants in 2025 and 2026, indicating ongoing reliance on capital raises.

Summary

  • Wrap Technologies, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on December 11, 2026.
  • The meeting agenda includes electing seven directors, ratifying the appointment of HTL International, LLC as independent auditors, and an advisory vote on executive compensation.
  • Key proposals for stockholder approval are: increasing authorized common stock from 200 million to 300 million shares, authorizing the issuance of common stock underlying Series C Preferred Stock (potentially exceeding 20% of outstanding shares), and approving an amended and restated 2017 Equity Compensation Plan to increase available shares by 10 million and extend its term.
  • Additional proposals include amending the charter to limit common stock holder voting on preferred stock amendments and authorizing adjournment of the meeting if necessary.
  • The Board of Directors unanimously recommends a FOR vote on all eight proposals.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, primarily due to the proactive steps being taken to ensure future operational flexibility and capital access, though the need for these measures suggests past financial constraints.

Positives

  • Proactive measures to increase authorized shares (from 200M to 300M) provide future flexibility for capital raising and strategic transactions.
  • The proposed amendment to the 2017 Equity Compensation Plan aims to attract and retain talent by increasing the share pool by 10 million shares and extending the plan's term.
  • The company is seeking to streamline corporate governance by amending the charter to allow preferred stock holders to vote on amendments solely affecting their series, reducing administrative burden.
  • The virtual meeting format allows for broader stockholder participation regardless of location.

Negatives

  • The significant increase in authorized shares (50%) and the proposal to issue shares underlying Series C Preferred Stock (potentially over 20%) indicate a potential for substantial dilution to existing common stockholders.
  • The need to increase authorized shares suggests past limitations in capital availability or strategic execution.
  • The Series C Preferred Stock terms include an 8% cumulative dividend (20% if a triggering event occurs) and a conversion price subject to significant downward adjustments (full ratchet price-based adjustment), which could be highly dilutive.
  • The company has a history of late Section 16(a) filings, indicating potential weaknesses in compliance processes.

Risks

  • Potential for significant dilution to existing common stockholders due to the proposed increase in authorized shares and the issuance of shares related to Series C Preferred Stock.
  • The Series C Preferred Stock's anti-dilution provisions and dividend terms could negatively impact the common stock price and ownership percentages.
  • The company's reliance on equity financing and potential for future capital raises could lead to further dilution.
  • The need for stockholder approval for share increases and equity plan amendments highlights the company's dependence on external capital and its potential impact on existing shareholder value.

Future Outlook

The company is seeking stockholder approval for proposals that will provide significant future flexibility in terms of capital raising and equity compensation. The increase in authorized shares and the potential issuance related to Series C Preferred Stock are key to future strategic and financing activities. The extension of the equity compensation plan is intended to support ongoing talent attraction and retention.

Management Comments

  • "We urge you to review these materials carefully and to vote your shares electronically via the Internet or by completing and returning the proxy card or voting instruction form."
  • "Whether you plan to attend the Annual Meeting or not, your vote is important."
  • "We believe that the A&R Incentive Plan, which increases the number of shares of Common Stock available for issuance pursuant to awards under the 2017 Plan and extends the term of the 2017 Plan to the tenth anniversary of the date of the Boards approval of the A&R Incentive Plan, reflects best practices in our industry and is appropriate to permit the grant of equity awards at expected levels for the future."
  • "The Board believes that combining the Chairman of the Board and PEO roles fosters clear accountability, effective decision-making and alignment on corporate strategy."

Industry Context

StockSavvy.ai notes that the proposed share increase and equity plan expansion are common strategies for growth-stage companies needing to secure future funding and incentivize talent, especially in competitive technology or specialized manufacturing sectors like Wrap Technologies operates in. However, the significant potential dilution from the Series C Preferred Stock terms is a notable risk factor that investors will scrutinize.

Comparison to Industry Standards

  • The proposed increase in authorized shares from 200 million to 300 million (a 50% increase) is substantial but not uncommon for companies anticipating significant future financing needs or strategic acquisitions. For instance, many early-stage biotech or tech companies often seek similar increases.
  • The extension and replenishment of equity compensation plans are standard practice across industries to retain key personnel. The proposed addition of 10 million shares to the plan, bringing the total to 30.5 million, aligns with industry norms for companies of similar size and growth stage.
  • The terms of the Series C Preferred Stock, particularly the 8% cumulative dividend (escalating to 20% upon a triggering event) and the 'full ratchet' anti-dilution protection, are aggressive. While such terms are sometimes seen in distressed financing or venture debt scenarios, they are less common in standard preferred equity offerings and suggest a higher risk profile or a strong negotiating position by the investors.
  • The proposal to limit common stockholder voting on preferred stock amendments is a governance change that can streamline decision-making but may reduce common stockholder influence on certain corporate actions, a practice that varies across industries and company governance philosophies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Charter AmendmentProposal to amend the Charter to provide that holders of Common Stock will not be entitled to vote on amendments relating solely to the terms of one or more outstanding series of preferred stock if the holders of the affected series are entitled to vote thereon.Upon stockholder approval and filingStreamlines the process for amending preferred stock terms, potentially reducing administrative costs and delays, but may reduce common stockholder influence on certain preferred stock-related matters.
Equity Compensation PlanProposal to approve the Amended and Restated 2017 Equity Compensation Plan, increasing the aggregate number of shares available for awards by 10,000,000 to a total of 30,500,000 shares and extending its term for an additional ten years.Upon stockholder approvalEnhances the company's ability to attract, retain, and motivate employees, directors, and consultants through equity incentives, while also potentially increasing dilution for existing shareholders.

Related Party Transactions

  • Scot Cohen (CEO, Executive Chairman) and V4 Global LLC participated in the Series A Preferred Stock issuance in June 2023, receiving 3,000 shares and warrants for $3 million. Mr. Cohen earned $300,000 in dividends on this stock in 2025.
  • Mr. Cohen (via V4 Global), Mr. Novick (via Continuum Ventures LLC), and Mr. Savas (via Savbo Investments LLC) participated in a private placement in February 2025, raising $5.8 million. Mr. Cohen's participation was $1.98 million, Mr. Novick's was $495,000, and Mr. Savas's was $90,000.
  • Mr. Cohen (via V4 Global) participated in a private placement in August 2025, receiving Series B Preferred Stock and warrants for $1 million.
  • Mr. Cohen (via V4 Global), Mr. Shulman (via Juggernaut Management, LLC), and Mr. Savas (via Savbo Investments LLC) participated in a private placement in February 2026, raising $5.0 million. Mr. Cohen's participation was $950,000, Mr. Shulman's was $500,000, and Mr. Savas's was $50,000.
  • Gerald Ratigan, former CFO, received a base salary of $200,000 and stock options, and later a severance payment of $50,000 upon his separation in October 2025.

Stakeholder Impact

  • Shareholders may experience dilution if the proposed increase in authorized shares and the issuance of Series C Preferred Stock lead to a significant increase in outstanding shares.
  • Employees and directors may benefit from the proposed expansion and extension of the equity compensation plan, aligning their interests with long-term company performance.
  • Preferred stockholders (specifically holders of Series C) have terms that could lead to significant dilution for common stockholders if certain conditions are met or not met.
  • The proposed charter amendment regarding voting on preferred stock amendments could reduce the voting power of common stockholders on specific corporate actions.

Next Steps

  • Stockholders to vote on proposals at the Annual Meeting on December 11, 2026.
  • If approved, the Board will have the authority to file amendments to the Charter to increase authorized shares and modify voting rights.
  • If approved, the Amended and Restated 2017 Equity Compensation Plan will be implemented.
  • The company will proceed with the exchange of Series A Preferred Stock for Series C Preferred Stock, pending stockholder approval of the Issuance Proposal.
  • HTL International, LLC will continue as the independent registered public accounting firm for the fiscal year ending December 31, 2026, subject to ratification.

Key Dates

DateDescription
2026-10-15Record Date for determining stockholders entitled to vote at the Annual Meeting.
2026-11-06Date proxy materials were sent to stockholders.
2026-12-10Deadline for Internet voting for stockholders of record.
2026-12-11Date of the Annual Meeting of Stockholders.
2027-03-15Deadline for stockholder approval of share increase under the 2017 Plan to avoid forfeiture of restricted stock for Mr. Cohen and Mr. Novick.
2027-03-27Termination date of the current 2017 Equity Compensation Plan if the A&R Incentive Plan is not approved.
2027-10-12Deadline for stockholders to provide notice for director nominations under Rule 14a-19 for the 2027 Annual Meeting.
2029Year of the next advisory vote on the frequency of executive compensation advisory votes.

Recommendation

hold

The company is taking necessary steps for future flexibility, but the significant potential for dilution from the Series C Preferred Stock and the need for such capital raises suggest a cautious approach. While the equity plan is positive for talent, the overall financial health and execution risk warrant a hold.

Keywords

Annual Meeting, Proxy Statement, Share Increase, Equity Compensation Plan, Series C Preferred Stock, Charter Amendment, Director Election, Auditor Ratification

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.